Aspiriant LLC’s Saic SAIC Stock Holding History

Aspiriant LLC’s Portfolio SAIC Stock Details SAIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-77,360	Closed	-$7.13M	–	288
2022 Q1	$7.13M	Hold	77,360	–	–	0.39%	38
2021 Q4	$6.47M	Buy	+77,360	New	+$6.72M	0.35%	40

Other funds holding SAIC

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Aspiriant LLC's SAIC Position: Q2 2022 in Review

Aspiriant LLC sold out of Saic (SAIC) in Q2 2022, closing a stake of 77,360 shares — an estimated $7.13M sold.

Aspiriant LLC first reported a position in SAIC in Q4 2021 and held it in 2 quarters. The position peaked at $7.13M in Q1 2022. 344 funds tracked by Wall St. Rank hold SAIC as of Q2 2022.

Aspiriant LLC reported no remaining Saic position as of Q2 2022 after selling out during the quarter.
Aspiriant LLC sold 77,360 Saic shares in Q2 2022, an estimated $7.13M.
Aspiriant LLC first reported a position in Saic in Q4 2021 and held it in 2 quarters.
Aspiriant LLC's Saic position peaked at $7.13M in Q1 2022.
344 funds tracked by Wall St. Rank held Saic as of Q2 2022.

Based on Aspiriant LLC's 13F filing for Q2 2022, filed 25 Jul 2022.